reverse-phase HPLC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-07-30. Numbers and descriptions here follow the published literature rather than marketing material.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
| Property | Value | Notes |
|---|---|---|
| Reconstitution solvent | Sterile water or aqueous buffer | Aseptic technique recommended |
| Post-reconstitution storage | 2–8 °C short term; frozen for longer periods | Avoid repeated freeze-thaw cycles |
| Typical purity assay | Reversed-phase HPLC | Peak area used to estimate purity |
| Identity confirmation | Mass measurement | Compares observed value with expected mass |
| Main degradation routes | Hydrolysis and oxidation | Accelerated by heat and extreme pH |
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Pharmacokinetics and pharmacodynamics are termed toxicokinetics and toxicodynamics in the field of ecotoxicology. Here, the focus is on toxic effects on a wide range of organisms. The corresponding models are called toxicokinetic-toxicodynamic models.
Although blood had been known to carry oxygen since at least 1794, the oxygen-carrying property of hemoglobin was described by Hünefeld in 1840. In 1851, German physiologist Otto Funke published a series of articles in which he described growing hemoglobin crystals by successively diluting red blood cells with a solvent such as pure water, alcohol or ether, followed by slow evaporation of the solvent from the resulting protein solution. Hemoglobin's reversible oxygenation was described a few years later by Felix Hoppe-Seyler. In 1825, Johann Friedrich Engelhart discovered that the ratio of iron to protein is identical in the hemoglobins of several species. From the known atomic mass of iron, he calculated the molecular mass of hemoglobin to n × 16000 (n=number of iron atoms per hemoglobin molecule, now known to be 4), the first determination of a protein's molecular mass. This "hasty conclusion" drew ridicule from colleagues who could not believe that any molecule could be so large. However, Gilbert Smithson Adair confirmed Engelhart's results in 1925 by measuring the osmotic pressure of hemoglobin solutions. With the development of X-ray crystallography, it became possible to solve protein structures. In 1959, Max Perutz determined the molecular structure of hemoglobin. For this work he shared the 1962 Nobel Prize in Chemistry with John Kendrew, who sequenced the globular protein myoglobin. The role of hemoglobin in the blood was elucidated by French physiologist Claude Bernard.
Alice in Chains were added as openers to Ozzy Osbourne's No More Tours tour. Days before the tour began, Staley broke his foot in an ATV accident, forcing him to use crutches on stage. During the tour, Starr was fired following the Hollywood Rock concert in Rio de Janeiro on January 22, 1993, and was replaced by former Ozzy Osbourne bassist Mike Inez. During June–August 1993, Alice in Chains joined Primus, Tool, Rage Against the Machine and Babes in Toyland for the alternative rock festival Lollapalooza, which was the last major tour the band played with Staley.
=== Indications === Levosimendan is indicated for inotropic support in acutely-decompensated severe congestive heart failure in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate. Some of the Phase III studies in the extensive clinical program including the trials LIDO (200 patients), RUSSLAN (500), REVIVE-I (100), REVIVE-II (600) and SURVIVE (1350). In total, the clinical data base includes more than 3500 patients in Phase IIb and III double-blind randomized studies. In the SURVIVE study, despite a reduction in plasma B-type natriuretic peptide level in patients in the levosimendan group compared with patients in the dobutamine group, levosimendan did not significantly reduce all-cause mortality at 180 days. However, in a retrospective subgroup analysis, Levosimendan was superior to dobutamine for treating patients with a history of CHF or those on beta-blocker therapy when they were hospitalized with acute decompensations.
Sources: en.wikipedia.org
=== 3 June === A missile strike on Dnipro killed a two-year-old girl and wounded 22 people after it hit a two-story building. Five of them were reportedly children, seventeen people were hospitalized and several were believed to have been trapped under the rubble. Belgorod Oblast Governor Vyacheslav Gladkov said that two people were killed by Ukrainian shelling.
The biological activity of heparin within species 6–11 is unclear and further supports the idea that the main physiological role of heparin is not anticoagulation. These species do not possess any blood coagulation system similar to that present within the species listed 1–5. The above list also demonstrates how heparin has been highly evolutionarily conserved, with molecules of a similar structure being produced by a broad range of organisms belonging to many different phyla.
Overlapping peptide libraries - in which the entirety of a larger protein is used to produce a library of 8-20 amino acid peptides which overlap; these libraries can be used to identify the specific regions of a larger protein which participate in a given interaction or to provide pre-digested versions of a larger protein for binding. Truncation peptide libraries - in which a given peptide is produced with various or all N or C terminal truncations, these smaller fragments can be used to identify the minimal required region of a peptide for a given interaction being studied. Random libraries - randomly generated peptides of a set length, or range of lengths, can be used to identify novel binding partners of a target of interest. Alanine scanning libraries - in which each amino acid of a given protein or peptide is replaced with an alanine sequentially such that each peptide contains only one alanine mutations but all possible mutations to alanine are present; this can be used to identify critical residues for binding Positional or scrambled peptide libraries - in which specific positions in the peptide are substituted for many or all other amino acids such that the effect of each amino acid at that position in the peptide on the binding or other activity of the peptide can be tested. Scrambled libraries are often random peptides and used as negative controls. Solid phase peptide synthesis is limited to a peptide chain length of approximately 70 amino acids and is generally unsuitable for the study of larger proteins.
=== 3D printing === In 2017, scientists from Chalmers University of Technology in Sweden demonstrated cartilage tissue engineering using 3D bioprinting. They used two different bioinks with nanofibrillated cellulose (NFC) to conduct the tests: NFC with alginate (NFC/A) and hyaluronic acid (NFC/HA). The bioinks were co-printed with irradiated human chondrocytes [8]. The team had success with NFC/A. In September 2021, researchers created cartilage repair implants utilizing a process of three-dimensional weaving to combine artificial materials with stem cells. The bioartificial implants are designed to partly dissolve over time, leaving only natural tissues in the repaired joints. As of October 2021, scientists have seen success in treating dogs but further research is required before the technique could move to clinical trials for humans. Also in September 2021, scientists from the Nakayama Lab at Saga University and Kyoto University in Japan fabricated 3D printed cartilage constructs from stem cells.
Natural fibers often show promise as biomaterials in medical applications. Chitin is notable in particular and has been incorporated into a variety of uses. Chitin based materials have also been used to remove industrial pollutants from water, processed into fibers and films, and used as biosensors in the food industry. Chitin has also been used several of medical applications. It has been incorporated as a bone filling material for tissue regeneration, a drug carrier and excipient, and as an antitumor agent. Insertion of foreign materials into the body often triggers an immune response, which can have a variety of positive or negative outcomes depending on the bodies response to the material. Implanting something made from naturally synthesized proteins, such as a keratin based implant, has the potential to be recognized as natural tissue by the body. This can lead either to integration in rare cases where the structure of the implant promotes regrowth of tissue with the implant forming a superstructure or degradation of the implant in which the backbones of the proteins are recognized for cleavage by the body.
Sources: en.wikipedia.org
=== Oxides === Curium readily reacts with oxygen forming mostly Cm2O3 and CmO2 oxides, but the divalent oxide CmO is also known. Black CmO2 can be obtained by burning curium oxalate (Cm2(C2O4)3), nitrate (Cm(NO3)3), or hydroxide in pure oxygen. Upon heating to 600–650 °C in vacuum (about 0.01 Pa), it transforms into the whitish Cm2O3:
== Reproduction and development == Eggs are laid in an ootheca which the female carries out the end of her abdomen for varying lengths of time. When ready she either deposits it on the ground, or attaches it to an object. The hardened ootheca helps protect the developing eggs. Optimal temperature range and patterns effect the hatch rate. Research has found that the best hatch rates occur when temperature alternates between 5°C and 30°C (the ootheca were left at the lower temperature for seven days, then left at the higher temperature for the remainder of development), the development time averages 44 days. Less effective temperature combinations may result in longer development times, alternating 10°C and 25°C, averages 61 days. E. sinensis is considered to have a flexible life cycle, as length can vary from 1 to 3 years, depending on latitude the population is from. Females can survive up to 30 months, while males lifespan is much shorter. The variable lifespans correlates to varying number of instars, 7 to 9, or 9 to 11. Males generally develop faster than females. The species takes longer to develop at lower temperatures.
This means that substitution models can be viewed as implying a specific multinomial distribution for site pattern frequencies. If we consider a multiple sequence alignment of four DNA sequences there are 256 possible site patterns so there are 255 degrees of freedom for the site pattern frequencies. However, it is possible to specify the expected site pattern frequencies using five degrees of freedom if using the Jukes-Cantor model of DNA evolution, which is a simple substitution model that allows one to calculate the expected site pattern frequencies only the tree topology and the branch lengths (given four taxa an unrooted bifurcating tree has five branch lengths). Substitution models also make it possible to simulate sequence data using Monte Carlo methods. Simulated multiple sequence alignments can be used to assess the performance of phylogenetic methods and generate the null distribution for certain statistical tests in the fields of molecular evolution and molecular phylogenetics. Examples of these tests include tests of model fit and the "SOWH test" that can be used to examine tree topologies.
1852: Ingouville and parts of Graville-l'Eure and Sanvic 1919: all of Graville-Sainte-Honorine 1953: Bleville 1955: all of Sanvic 1971: part of Harfleur (a district of Caucriauville) 1973: Rouelles (with the status of associated commune, 3,184 inhabitants in 2006)
=== 1980s === 1982: Nephrologist Leah Lowenstein became the first woman dean of a co-educational medical school in the United States. 1983: Barbara McClintock received the Nobel Prize in Physiology or Medicine for her discovery of genetic transposition; she was the first woman to receive that prize without sharing it, and the first American woman to receive any unshared Nobel Prize. 1984: Kathryn D. Sullivan becomes the first American woman to walk in space. 1988: Patricia Bath was the first African American woman to receive a medical patent, which was her invention of laser cataract treatment. 1988: Gertrude B. Elion received the Nobel Prize in Physiology or Medicine along with James W. Black and George H. Hitchings "for their discoveries of important principles for drug treatment".
Sources: en.wikipedia.org
Standard practice is a desiccated container at −20 °C, protected from light and kept sealed between uses. Letting the vial reach room temperature before opening reduces condensation on the powder. Repeated warming and cooling of the whole container is generally avoided.
There is no broadly accepted figure for TB-500. Laboratory practice is short-term storage at 2–8 °C with longer-term aliquots frozen, and degradation is expected to increase with time and temperature. Users typically rely on their own stability checks rather than published data.
Mass measurement provides the clearest confirmation by matching an observed value to the expected one. Reversed-phase chromatography adds a purity estimate through peak integration. Combining both is standard because neither alone establishes identity and purity together.
Short transit at ambient temperature is generally tolerated, but long-term storage at room temperature is not recommended. Heat, moisture, and light all accelerate degradation. Cold, dry, dark storage is the conventional choice.